Your browser doesn't support javascript.
loading
Synergistic Effects of Venetoclax and Daratumumab on Antibody-Dependent Cell-Mediated Natural Killer Cytotoxicity in Multiple Myeloma.
Nakamura, Ayano; Suzuki, Susumu; Kanasugi, Jo; Ejiri, Masayuki; Hanamura, Ichiro; Ueda, Ryuzo; Seto, Masao; Takami, Akiyoshi.
Affiliation
  • Nakamura A; Department of Internal Medicine, Division of Hematology, Aichi Medical University School of Medicine, Nagakute 480-1195, Japan.
  • Suzuki S; Research Creation Support Center, Aichi Medical University, Nagakute 480-1195, Japan.
  • Kanasugi J; Department of Tumor Immunology, Aichi Medical University School of Medicine, Nagakute 480-1195, Japan.
  • Ejiri M; Department of Internal Medicine, Division of Hematology, Aichi Medical University School of Medicine, Nagakute 480-1195, Japan.
  • Hanamura I; Department of Pharmacy, University Hospital, Aichi Medical University, Nagakute 480-1195, Japan.
  • Ueda R; Department of Internal Medicine, Division of Hematology, Aichi Medical University School of Medicine, Nagakute 480-1195, Japan.
  • Seto M; Department of Tumor Immunology, Aichi Medical University School of Medicine, Nagakute 480-1195, Japan.
  • Takami A; Department of Internal Medicine, Division of Hematology, Aichi Medical University School of Medicine, Nagakute 480-1195, Japan.
Int J Mol Sci ; 22(19)2021 Oct 05.
Article de En | MEDLINE | ID: mdl-34639102

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Cellules tueuses naturelles / Protocoles de polychimiothérapie antinéoplasique / Synergie des médicaments / Cytotoxicité à médiation cellulaire dépendante des anticorps / Myélome multiple Type d'étude: Prognostic_studies Limites: Humans Langue: En Journal: Int J Mol Sci Année: 2021 Type de document: Article Pays d'affiliation: Japon Pays de publication: Suisse

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Cellules tueuses naturelles / Protocoles de polychimiothérapie antinéoplasique / Synergie des médicaments / Cytotoxicité à médiation cellulaire dépendante des anticorps / Myélome multiple Type d'étude: Prognostic_studies Limites: Humans Langue: En Journal: Int J Mol Sci Année: 2021 Type de document: Article Pays d'affiliation: Japon Pays de publication: Suisse